Subtherapeutic erythropoietin and insulin-like growth factor-1 correct the anemia of chronic renal failure in the mouse

Kidney International

Volumn 50, Issue 3, 1996, Pages 937-943

  Brox, Alan G ^a   Zhang, Feng ^b   Guyda, Harvey ^b   Gagnon, Raymonde F ^b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; SOMATOMEDIN C;

ANEMIA; ANIMAL EXPERIMENT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029763716     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.394     Document Type: Article

References (46)

1. SPIVAK JL: Recombinant erythropoietin. Annu Rev Med 44:243-253, 1993
2. PAGANINI EP, MILLER T: Erythropoietin therapy in renal failure. Adv Intern Med 38:223-243, 1993
3. HUMPHRIES JE: Anemia of renal failure. Use of erythropoietin. Med Clin N Am 76:711-725, 1992
4. ADAMSON JW: The promise of recombinant human erythropoietin. Semin Hematol 26:5-8, 1989
5. PAPAYANNOPOULOU T, BRICE M, BLAU CA: Kit ligand in synergy with interlcukin-3 amplifies the erythropoietin-indepcndent, globin-synthesizing progeny of normal human hurst-forming units-erythroid in suspension cultures: Physiologic implications. Blood 81:299-310, 1993
6. WODNAR-FILIPOWICZ A, TICHELLI A, ZSEBO KM, SPECK B, NISSEN C: Stem cell factor stimulates the in vitro growth of bone marrow cells from aplastic anemia patients. Blood 79:3196-3202, 1992
7. MCNIECE IK, LANGLEY KE, ZSEBO KM: Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226-231, 1991
8. BROX A, CONGOTE LF, FAFARD J, FAUSER AA: Identification and characterization of an 8-kd peptide stimulating erythropoiesis. Exp Hematol 17:769-773, 1989
9. CONGOTE LF, BROX A, LIN FK, LU HS, FAUSER AA: The N-terminal sequence of the major erythropoietic factor of an anephric patient is identical to insulin-like growth factor 1. J Clin Endocrinol Metab 72:727-729, 1991
10. SANDERS M, SORBA S, DAINIAK N: Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exp Hematol 21:25-30, 1993
11. MERCHAV S, SILVIAN-DRACHSLER I, TATARSKY I, LAKE M, SKOTTNER A: Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factors-I and -II. J Clin Endocrinol Metab 74:447-452, 1992
12. ARON DC: Insulin-like growth factor I and erythropoiesis. Biofactors 3:211-216, 1992
13. CORREA PN, AXELRAD AA: Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: Role of insulin-like growth factor 1. Blood 78:2823-2833, 1991
14. SAWADA K, KRANTZ SB, DESSYPRIS EN, KOLIRY ST, SAWYER ST: Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 83:1701-1709, 1989
15. AKAHANE K, TOJO A, TAKAKU F: Binding properties and proliferative potency of insulin like growth factor 1 in fetal mouse liver cells. Exp Hematol 15:1068-1073, 1987
16. DAINIAK N: Control of hematopoietic cell growth by somatomedins. Exp Hematol 21:1405-1407, 1993
17. GAGNON RF, DUGUID WP: A reproducible model of chronic renal failure in the mouse. Urol Res 11:11-14, 1983
18. GAGNON RF, GOLD J, GERSTEIN W: A mouse model for delayed-type hypersensitivity skin changes in chronic renal failure. Uremia Invest 8:121-125, 1984
19. GAGNON RF, LU DSK: Mechanism of depressed immunity in chronic renal failure: Effect of cyclophosphamide pretreatment on delayedtype hypersensitivity skin reaction. J Lab Clin Immunol 18:135-140, 1985
20. GALLIMORE B, GAGNON RF, RICHARDS GK: Response to intraperitoneal Staphylococcus epidermidis challenge in renal failure mice. Kidney Int 32:678-683, 1987
21. GAGNON RF, GALLIMORE B: Characterization of a mouse model of chronic uremia. Urol Res 16:119-126, 1988
22. GALLIMORE B, GAGNON RF, RICHARDS GK: Role of an intraperitoneal catheter implant in the pathogenesis of experimental Staphylococcus epidermidis peritoneal infection in renal failure mice. Am J Nephrol 8:334-343, 1988
23. STEWART PHILLIPS JL, GAGNON RF, LOUGH J: Atherosclerosis in uremic mice. Trans Am Soc Artif Intern Organs 35:631-634, 1989
24. GAGNON RF, ANSARI M: Development and progression of uremic changes in the mouse with surgically-induced renal failure. Nephron 54:70-76, 1990
25. GALLIMORE B, GAGNON RF, RICHARDS GK: Kinetics of Staphylococcus epidermidis clearance from the peritoneal catheter site of renal failure mice following intracatheter inoculation. Am J Nephrol 10:77-86, 1990
26. SUBANG MC, STEWART PHILLIPS JL, PAPPU AS, SUBANG R, GAGNON RF: Possible role of mevalonate in the hypercholesterolemia seen in experimental chronic renal failure. Nephrom 69:151-154, 1995
27. COSTIGAN DC, GUYDA HJ, POSNER BI: Free insulin-like growth factor I (IGF-I) and IGF-II in human saliva. J Clin Endocrinol Metab 66:1014-1018, 1988
28. GRETZ N, LASSARE J, KRAFT K, WALDHERR R, MEISINGER E, STRAUCH M: Efficacy and side effects of erythropoietin used in the treatment of anemia of uremic rats. Contr Nephrol 60:236-244, 1988
29. VAN STONE JC, MAX P: Effect of erythropoietin on anemia of peritoneally dialyzed anephric rats. Kidney Int 15:370-375, 1979
30. DAI CH, KRANTZ SB, ZSEBO KM: Human hurst-forming unitserythroid need direct interaction with stem cell factor for further development. Blood 78:2493-2497, 1991
31. BROUDY VC, MORGAN DA, LIN N, ZSEBO KM, JACOBSEN FW, PAPAYANNOPOULOU T: Stem cell factor influences the proliferation and erythroid differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor. Blood 82:436-444, 1993
32. BOYER SH, BISHOP TR, ROGERS OC, NOYES AN, FRELIN LP, HOBBS S: Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood 80:2503-2512, 1992
33. MIGLIACCIO G, MIGLIACCIO AR, DRUZIN ML, GIARDINA PJ, ZSEBO KM, ADAMSON JW: Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro. J Cell Physiol 148:503-509, 1991
34. KURTZ A, ZAPF J, ECKARDT E, CLEMONS G, BAUER C: Insulin-like growth factor-1 stimulates erythropoiesis in hypophysectomized rats. Proc Nat Acad Sci USA 85:7825-7829, 1988
35. BECHENSTEEN AG, HALVORSEN S, SKOTTNER A: Recombinant human insulin-like growth factor 1 stimulates erythropoiesis in adult, but not in newborn mice. Acta Physiol Scand 151:117-123, 1994
36. ZHANG F, LANEUVILLE P, GAGNON RF, MORIN B, BROX AG: Effect of chronic renal failure on the expression of erythropoietin message in a murine model. Exp Hematol (in press)
37. BLUM WF, RANKE MB, KIETZMANN K, TONSHOFF B, MEHLS O: Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding proteins in uremia. Pediatr Nephrol 5:539-544, 1991
38. POWELL DR, ROSENFELD RG, SPERRY JB, BAKER BK, HINTZ RL: Serum concentrations of insulin-like growth factor 1 and IGF2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 10:287-292, 1987
39. LEE PDK, CONOVER C, POWELL DR: Regulation and function of insulin-like growth factor binding protein 1. Proc Soc Exp Biol 204:4-29, 1994
40. BLAT C, VILLAUDY J, BINOUX M: In vivo proteolysis of serum-insulin-like growth factor binding protein 3 results in increased availability of IGF to target cells. J Clin Invest 93:2286-2290, 1994
41. DROP SLS, SCHULLER AGP, LINDENBERGH-KORTLEVE DJ, GROFFEN C, BRINKMAN A: Structural aspects of the IGFBP family. Growth Reg 2:69-79, 1992
42. PHILIPS LS, FUSCO AC, UNTERMAN TG, DELGRECO F: Somatomedin inhibitors in uremia. J Clin Endocrinol Metab 59:764-772, 1984
43. BLUM WF: Insulin like growth factors(IGFs) and IGF binding proteins in chronic renal failure: Evidence for reduced secretion of IGF. Acta Pediatr Scand 379:24-31, 1991
44. LEE D, PARK SW, YORGIN PD, COHEN P, ROSENFELD RG: Alteration in insulin-like growth factor binding proteins and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 79:1376-1382, 1994
45. CARLSSON-SKWIRUT C, LAKE M, HARTMANIS M, HALL K, SARA VR: A comparison of the biological activity of the recombinant intact and truncated insulin like growth factor 1 (IGF1). Biochem Biophys Acta 1011:192-197, 1989
46. CASCIERI MA: Serum half-life and biological activity of mutants of human insulin-like growth factor 1 which do not bind to serum binding proteins. Endocrinology 123:373-381, 1988